← Back to Search

Perfusion Enhancement System

Study Arm for Ischemic Stroke

N/A
Waitlist Available
Led By Fern Cudlip, MSN FNP CNRN
Research Sponsored by TurnCare Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the time frame will be up to and including 24 months
Awards & highlights

Study Summary

This is a non-blinded randomized study that will investigate whether the use of a novel, non-invasive perfusion enhancement system (The Guardian System) impacts motor recovery and hospital length of stay in acute ischemic stroke patients.

Eligible Conditions
  • Ischemic Stroke
  • Stroke

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the time frame will be up to and including 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and the time frame will be up to and including 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Length of Stay Reduction in Acute Ischemic Stroke Patients in the Control and Study Arm Groups

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Study ArmExperimental Treatment1 Intervention
The Study Arm will have the non-invasive perfusion enhancement system placed on their beds and recovery chairs. Patients will be utilizing the systems while lying in bed or sitting in the chair.
Group II: Control GroupActive Control1 Intervention
The Control Group will receive the standard support surface mattresses/bed surfaces and recovery chairs without the non-invasive perfusion enhancement system (The Guardian System)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Guardian System
2008
Completed Phase 3
~1020

Find a Location

Who is running the clinical trial?

TurnCare Inc.Lead Sponsor
1 Previous Clinical Trials
431 Total Patients Enrolled
Fern Cudlip, MSN FNP CNRNPrincipal InvestigatorGood Samaritan Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study of the Guardian System on Motor Recovery and Impact on Length of Stay in Ischemic Stroke Patients
2018. "Study of the Guardian System on Motor Recovery and Impact on Length of Stay in Ischemic Stroke Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03673241.
All > Anterior Ischemic Optic Neuropathy
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top